Shell
Home | This Week's Contents  |  C&EN ClassifiedsSearch C&EN Online

 
Related Site
NIH
E-mail this article to a friend
Print this article
E-mail the editor
 
 
 
 
 
 
 Table of Contents
 C&EN Classifieds
 News of the Week
 Cover Story
 Editor's Page
 Business
 Government & Policy
 Science/Technology
 Concentrates
  Business
  Government & Policy
  Science/Technology
 Education
 ACS News
 Calendars
 Books
 Digital Briefs
 ACS Comments
 Career & Employment
 Special Reports
 Letters
 Newscripts
 Nanotechnology
 What's That Stuff?
 Pharmaceutical Century

 Hot Articles
 Safety  Letters
 Chemcyclopedia

 Back Issues

 How to Subscribe
 Subscription Changes
 About C&EN
 Copyright Permission
 E-mail webmaster
NEWS OF THE WEEK
GOVERNMENT
April 1, 2002
Volume 80, Number 13
CENEAR 80 13 p. 12
ISSN 0009-2347
[Previous Story] [Next Story]

BUSH NAMES NIH DIRECTOR
Elias Zerhouni praised for mix of clinical, scientific, and business skills

WILLIAM SCHULZ

As expected, last week president George W. Bush announced that his pick to head the National Institutes of Health is radiologist Elias A. Zerhouni, executive vice dean of the Johns Hopkins School of Medicine, Baltimore.

Health & Human Services Secretary Tommy G. Thompson said Zerhouni has the "experience creating the kind of research efforts and teams that pursue and find answers to some of the great medical mysteries we face today," including cancer and diabetes.

Bush's decision ends weeks of speculation about who might lead the sprawling health agency.

Bush also announced that he will name Tucson trauma surgeon Richard H. Carmona to be surgeon general. Both nominations need Senate confirmation.

Johns Hopkins University President William R. Brody calls Zerhouni's nomination "outstanding." He says Zerhouni's "mix of clinical, scientific, and administrative abilities is particularly important during this period of significant growth in the NIH budget and rapid advances in biomedical science."

Zerhouni's research has focused on the development of methods for imaging cardiopulmonary disease. For example, he developed the method of computed tomography (CT) densitometry for differentiating benign from malignant pulmonary nodules, high-resolution CT for lung disease, and magnetic resonance tagging for quantifying myocardial function.

Zerhouni is able to "convince people with differing agendas to search for common ground," says Morton Goldberg, director of the Wilmer Eye Institute at Johns Hopkins. As a clinician, researcher, and businessman--who put together a radiology practice--he says, Zerhouni's "got the whole package."

[Previous Story] [Next Story]



Top


Chemical & Engineering News
Copyright © 2002 American Chemical Society


Home | Table of Contents | News of the Week | Cover Story
Business | Government & Policy | Science/Technology
Chemical & Engineering News
Copyright © 2002 American Chemical Society - All Right Reserved
1155 16th Street NW • Washington DC 20036 • (202) 872-4600 • (800) 227-5558


CASChemPortChemCenterPubs Page